Feature Channels:

Clinical Trials

Add to Favorites Subscribe Share
fbshare-Clinical Trials

Showing results

110 of 23
  • Embargo expired:
    18-Apr-2019 5:00 PM EDT

Article ID: 711227

Investigators Incorporate Randomized Trial within Dialysis Care Delivery

American Society of Nephrology (ASN)

• The Time to Reduce Mortality in ESRD (TiME) trial was a large pragmatic trial demonstration project designed to determine the benefits of hemodialysis sessions that are longer than many patients currently receive. • The trial was conducted through a partnership between academic investigators and 2 large dialysis provider organizations using a highly centralized implementation approach. • Although the trial accomplished most of its demonstration project objectives, uptake of the intervention was insufficient to determine whether longer sessions improve outcomes.

12-Apr-2019 9:00 AM EDT
  • Embargo expired:
    18-Apr-2019 11:00 AM EDT

Article ID: 711254

Microbiomes of diabetic foot ulcers are associated with clinical outcomes

University of Wisconsin-Madison

New research suggests that the microbial communities associated with chronic wounds common in diabetic patients affect whether those wounds heal or lead to amputations.

12-Apr-2019 1:05 PM EDT

Article ID: 711542

Baby step towards breath-testing for gut disorders

Flinders University

Small children may one day avoid invasive, painful and often traumatic oesophageal tube-testing for gut damage and coeliac disease with a new method of simply blowing into a glass tube to provide effective diagnoses. Research published in international journal Scientific Reports describes an exciting new breath test that could have global implications on how to detect gastrointestinal damage.

17-Apr-2019 11:05 PM EDT

Article ID: 711407

Magic Mouthwash effective treatment for mouth sore pain caused by radiation therapy

Mayo Clinic

“Magic mouthwash,” an oral rinse containing diphenhydramine, lidocaine and antacids, significantly reduced pain from oral mucositis, mouth sores, in patients receiving radiation therapy for cancers of the head and neck when compared to plaecbo. These were the findings of a multi-institution, randomized, double-blind, placebo-controlled, phase III clinical trial, led by Robert Miller, M.D., an emeritus Mayo Clinic radiation oncologist. Dr. Miller and his colleagues published their findings on Tuesday, April 16, in JAMA.

16-Apr-2019 11:00 AM EDT

Article ID: 711406

'PRO-cision Medicine' Aims to Turn Patient-Reported Outcome Ratings into Personalized Care

Wolters Kluwer Health: Lippincott Williams and Wilkins

Patient-reported outcomes (PROs) are an important target for efforts to improve healthcare – focusing on the most important problems and outcomes identified by patients themselves. A special supplement to Medical Care presents a toolkit of methods to help personalize care for patients with cancer using a 'PRO cision Medicine' approach. The journal is published in the Lippincott portfolio by Wolters Kluwer.

16-Apr-2019 9:05 AM EDT

Article ID: 711539

UCSF Study Aims to Increase Diversity in Cancer Clinical Trials

UCSF Helen Diller Family Comprehensive Cancer Center

UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved populations, including low-income individuals and racial and ethnic minorities.

15-Apr-2019 8:05 PM EDT

Article ID: 711343

Gene-Based Factor VIIa Prevents Bleeding Episodes in Animals with Hemophilia

Children's Hospital of Philadelphia

Hematology researchers have further refined how a treatment currently used urgently to control bleeding in hemophilia patients holds promise for prevention as well. A study in animals may lead to a new therapy for patients who now develop antibodies to the standard maintenance treatment.

15-Apr-2019 2:30 PM EDT

Article ID: 711331

Endocrine Society holds first-ever Latin American Leadership Academy at ENDO 2019

Endocrine Society

Through partnerships with Sanofi Argentina, Sanofi Chile, Sanofi Colombia, Sanofi Pacific and Caribbean, Sanofi Peru and Sanofi Uruguay, the Endocrine Society hosted its first Latin American (LATAM) Leadership Academy. Sixty-two clinicians from over 15 countries across South America, Central America and the Caribbean took part in a one-day leadership training program and attended ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.

15-Apr-2019 12:05 PM EDT

Showing results

110 of 23

Chat now!